Trajectory, interactions, and predictors of higher symptom burden during induction therapy for multiple myeloma
Almost one-third of MM patients suffer from up to 5 moderate to severe symptoms persistently, including pain, muscle weakness, numbness, disturbed sleep, and fatigue. Importantly, these results identify a group of symptoms that should be monitored and managed as part of routine patient care during MM induction therapy and suggest that pre-therapy pain management is necessary for better symptom control.
Authors
- Charles S. Cleeland (ORCID: https://orcid.org/0000-0002-1460-6527)
- Xin Shelley Wang (ORCID: https://orcid.org/0000-0003-2348-8005)
- Mona Kamal (ORCID: https://orcid.org/0000-0003-1626-2657)
- Qiuling Shi (ORCID: https://orcid.org/0000-0003-0660-3809)
- Shu‐En Shen (ORCID: https://orcid.org/0000-0002-7578-5397)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1186/s41687-024-00817-6
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- National Cancer Institute